DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man, BS; Brian Wynne, MD; Vani Vannappagari, MBBS, MPH, PhD Dr. Brennan and and Ms. Man are with Clinical Development and

Risk Management: Licensing Board Complaints: What You Need To Know

By Ann McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The authors

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

By Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received

Letter to the Editor: Regarding Zika Microcephaly

By Beuy Joob, PhD, and Viroj Wiwanitkit, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the

Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?

By Benjamin K.P. Woo, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

Dear Colleagues: Welcome to the May–June 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start the issue with a timely review article by Touma and Scarff titled, “Valbenazine and